Ortho Earnings: Stryker Plans Big Compliance Investment In 2009
This article was originally published in The Gray Sheet
Executive Summary
Stryker will spend between $60 million and $90 million on compliance initiatives in 2009, as it overhauls its quality standards and resolves issues related to three outstanding FDA warning letters
You may also be interested in...
Stryker’s Equipment Sales Boost Third-Quarter Results
In a quarterly call with analysts on Oct. 19, Stryker executives touted the company’s product diversity as a key to the company reporting a steady quarter at a time when orthopedic companies still struggle.
Stryker’s Equipment Sales Boost Third-Quarter Results
In a quarterly call with analysts on Oct. 19, Stryker executives touted the company’s product diversity as a key to the company reporting a steady quarter at a time when orthopedic companies still struggle.
Stryker Wraps Up Last Of FDA Warning Letters, Pledges To Retain QSR Focus
Stryker has resolved the last of four FDA warning letters, but the company maintains its efforts to improve quality systems company-wide will continue